APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor IX

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Coagulation Factor IX Industry Growth and Trends Forecast to 2032

Report ID 173979030120 December 202590 pages

Choose your research edition.

Industry ResearchCoagulation Factor IX Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor IX Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Coagulation Factor IX Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor IX Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor IX Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Coagulation Factor IX market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coagulation Factor IX is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coagulation Factor IX include Takeda, Novo Nordisk, Pfizer, Baxter, Sanquin, Grifols, CSL Behring, Bioverativ and Aptevo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Coagulation Factor IX market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Coagulation Factor IX market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Coagulation Factor IX market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Coagulation Factor IX.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Coagulation Factor IX market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Coagulation Factor IX Market by Company

Takeda

Novo Nordisk

Pfizer

Baxter

Sanquin

Grifols

CSL Behring

Bioverativ

Aptevo

Coagulation Factor IX Segment by Type

Coagulation Factor IX (Plasma Derived)

Coagulation Factor IX (Recombinant)

Coagulation Factor IX Segment by Application

Adult

Kids

Coagulation Factor IX Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor IX market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor IX and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor IX.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Coagulation Factor IX manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Coagulation Factor IX in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Coagulation Factor IX (Plasma Derived) Table 2. Major Company of Coagulation Factor IX (Recombinant) Table 3. Global Coagulation Factor IX Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 5. Global Coagulation Factor IX Sales Market Share in Volume by Type (2021-2026) Table 6. Global Coagulation Factor IX Sales by Type (2021-2026) & (US$ Million) Table 7. Global Coagulation Factor IX Sales Market Share in Value by Type (2021-2026) Table 8. Global Coagulation Factor IX Price by Type (2021-2026) & (US$/Unit) Table 9. Global Coagulation Factor IX Sales by Type (2027-2032) & (W Units) Table 10. Global Coagulation Factor IX Sales Market Share in Volume by Type (2027-2032) Table 11. Global Coagulation Factor IX Sales by Type (2027-2032) & (US$ Million) Table 12. Global Coagulation Factor IX Sales Market Share in Value by Type (2027-2032) Table 13. Global Coagulation Factor IX Price by Type (2027-2032) & (US$/Unit) Table 14. North America Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 15. North America Coagulation Factor IX Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 17. Europe Coagulation Factor IX Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Coagulation Factor IX Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 21. Latin America Coagulation Factor IX Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Coagulation Factor IX Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Coagulation Factor IX Sales by Type (2021-2026) & (US$ Million) Table 24. Coagulation Factor IX Industry Trends Table 25. Coagulation Factor IX Industry Drivers Table 26. Coagulation Factor IX Industry Opportunities and Challenges Table 27. Coagulation Factor IX Industry Restraints Table 28. Global Coagulation Factor IX Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Coagulation Factor IX Revenue Market Share by Company (2021-2026) Table 30. Global Coagulation Factor IX Sales by Company (2021-2026) & (W Units) Table 31. Global Coagulation Factor IX Sales Share by Company (2021-2026) Table 32. Global Coagulation Factor IX Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Coagulation Factor IX Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Coagulation Factor IX Major Company Production Sites and Headquarters Table 35. Global Coagulation Factor IX Company, Product Type & Application Table 36. Global Coagulation Factor IX Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Coagulation Factor IX by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Coagulation Factor IX Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Coagulation Factor IX Sales by Region (2021-2026) & (W Units) Table 41. Global Coagulation Factor IX Sales Market Share in Volume by Region (2021-2026) Table 42. Global Coagulation Factor IX Sales by Region (2021-2026) & (US$ Million) Table 43. Global Coagulation Factor IX Sales Market Share in Value by Region (2021-2026) Table 44. Global Coagulation Factor IX Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Coagulation Factor IX Sales by Region (2027-2032) & (W Units) Table 46. Global Coagulation Factor IX Sales Market Share in Volume by Region (2027-2032) Table 47. Global Coagulation Factor IX Sales by Region (2027-2032) & (US$ Million) Table 48. Global Coagulation Factor IX Sales Market Share in Value by Region (2027-2032) Table 49. Global Coagulation Factor IX Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Coagulation Factor IX Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 52. Global Coagulation Factor IX Sales Market Share in Volume by Application (2021-2026) Table 53. Global Coagulation Factor IX Sales by Application (2021-2026) & (US$ Million) Table 54. Global Coagulation Factor IX Sales Market Share in Value by Application (2021-2026) Table 55. Global Coagulation Factor IX Price by Application (2021-2026) & (US$/Unit) Table 56. Global Coagulation Factor IX Sales by Application (2027-2032) & (W Units) Table 57. Global Coagulation Factor IX Sales Market Share in Volume by Application (2027-2032) Table 58. Global Coagulation Factor IX Sales by Application (2027-2032) & (US$ Million) Table 59. Global Coagulation Factor IX Sales Market Share in Value by Application (2027-2032) Table 60. Global Coagulation Factor IX Price by Application (2027-2032) & (US$/Unit) Table 61. North America Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 62. North America Coagulation Factor IX Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 64. Europe Coagulation Factor IX Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Coagulation Factor IX Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 68. Latin America Coagulation Factor IX Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Coagulation Factor IX Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Coagulation Factor IX Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Takeda Coagulation Factor IX Product Portfolio Table 75. Takeda Recent Development Table 76. Novo Nordisk Company Information Table 77. Novo Nordisk Business Overview Table 78. Novo Nordisk Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Novo Nordisk Coagulation Factor IX Product Portfolio Table 80. Novo Nordisk Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Coagulation Factor IX Product Portfolio Table 85. Pfizer Recent Development Table 86. Baxter Company Information Table 87. Baxter Business Overview Table 88. Baxter Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Baxter Coagulation Factor IX Product Portfolio Table 90. Baxter Recent Development Table 91. Sanquin Company Information Table 92. Sanquin Business Overview Table 93. Sanquin Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sanquin Coagulation Factor IX Product Portfolio Table 95. Sanquin Recent Development Table 96. Grifols Company Information Table 97. Grifols Business Overview Table 98. Grifols Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Grifols Coagulation Factor IX Product Portfolio Table 100. Grifols Recent Development Table 101. CSL Behring Company Information Table 102. CSL Behring Business Overview Table 103. CSL Behring Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. CSL Behring Coagulation Factor IX Product Portfolio Table 105. CSL Behring Recent Development Table 106. Bioverativ Company Information Table 107. Bioverativ Business Overview Table 108. Bioverativ Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Bioverativ Coagulation Factor IX Product Portfolio Table 110. Bioverativ Recent Development Table 111. Aptevo Company Information Table 112. Aptevo Business Overview Table 113. Aptevo Coagulation Factor IX Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Aptevo Coagulation Factor IX Product Portfolio Table 115. Aptevo Recent Development Table 116. North America Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 117. North America Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 118. North America Coagulation Factor IX Sales Market Share by Country (2021-2026) Table 119. North America Coagulation Factor IX Sales Forecast by Country (2027-2032) & (W Units) Table 120. North America Coagulation Factor IX Sales Market Share Forecast by Country (2027-2032) Table 121. North America Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Coagulation Factor IX Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Coagulation Factor IX Market Share by Country (2021-2026) Table 124. North America Coagulation Factor IX Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Coagulation Factor IX Market Share Forecast by Country (2027-2032) Table 126. Europe Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 127. Europe Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 128. Europe Coagulation Factor IX Sales Market Share by Country (2021-2026) Table 129. Europe Coagulation Factor IX Sales Forecast by Country (2027-2032) & (W Units) Table 130. Europe Coagulation Factor IX Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Coagulation Factor IX Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Coagulation Factor IX Market Share by Country (2021-2026) Table 134. Europe Coagulation Factor IX Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Coagulation Factor IX Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 138. Asia-Pacific Coagulation Factor IX Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Coagulation Factor IX Sales Forecast by Country (2027-2032) & (W Units) Table 140. Asia-Pacific Coagulation Factor IX Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Coagulation Factor IX Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Coagulation Factor IX Market Share by Country (2021-2026) Table 144. Asia-Pacific Coagulation Factor IX Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Coagulation Factor IX Market Share Forecast by Country (2027-2032) Table 146. Latin America Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 147. Latin America Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 148. Latin America Coagulation Factor IX Sales Market Share by Country (2021-2026) Table 149. Latin America Coagulation Factor IX Sales Forecast by Country (2027-2032) & (W Units) Table 150. Latin America Coagulation Factor IX Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Coagulation Factor IX Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Coagulation Factor IX Market Share by Country (2021-2026) Table 154. Latin America Coagulation Factor IX Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Coagulation Factor IX Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Coagulation Factor IX Sales by Country (2021-2026) & (W Units) Table 158. Middle East and Africa Coagulation Factor IX Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Coagulation Factor IX Sales Forecast by Country (2027-2032) & (W Units) Table 160. Middle East and Africa Coagulation Factor IX Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Coagulation Factor IX Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Coagulation Factor IX Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Coagulation Factor IX Market Share by Country (2021-2026) Table 164. Middle East and Africa Coagulation Factor IX Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Coagulation Factor IX Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Coagulation Factor IX Distributors List Table 169. Coagulation Factor IX Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Coagulation Factor IX Image Figure 2. Global Coagulation Factor IX Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coagulation Factor IX Market Size (2021-2032) & (US$ Million) Figure 4. Global Coagulation Factor IX Sales (2021-2032) & (W Units) Figure 5. Coagulation Factor IX (Plasma Derived) Image Figure 6. Global Coagulation Factor IX (Plasma Derived) Sales YoY Growth (2021-2032) & (W Units) Figure 7. Coagulation Factor IX (Recombinant) Image Figure 8. Global Coagulation Factor IX (Recombinant) Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Coagulation Factor IX Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Coagulation Factor IX Market Share by Type 2025 VS 2032 Figure 11. North America Coagulation Factor IX Sales Market Share in Volume by Type in 2025 Figure 12. North America Coagulation Factor IX Sales Market Share in Value by Type in 2025 Figure 13. Europe Coagulation Factor IX Sales Market Share in Volume by Type in 2025 Figure 14. Europe Coagulation Factor IX Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Coagulation Factor IX Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Coagulation Factor IX Sales Market Share in Value by Type in 2025 Figure 17. Latin America Coagulation Factor IX Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Coagulation Factor IX Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Coagulation Factor IX Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Coagulation Factor IX Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Coagulation Factor IX Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Adult Image Figure 24. Global Adult Sales YoY Growth (2021-2032) & (W Units) Figure 25. Kids Image Figure 26. Global Kids Sales YoY Growth (2021-2032) & (W Units) Figure 27. Global Coagulation Factor IX Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Coagulation Factor IX Market Share by Application 2025 VS 2032 Figure 29. North America Coagulation Factor IX Sales Market Share in Volume by Application in 2025 Figure 30. North America Coagulation Factor IX Sales Market Share in Value by Application in 2025 Figure 31. Europe Coagulation Factor IX Sales Market Share in Volume by Application in 2025 Figure 32. Europe Coagulation Factor IX Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Coagulation Factor IX Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Coagulation Factor IX Sales Market Share in Value by Application in 2025 Figure 35. Latin America Coagulation Factor IX Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Coagulation Factor IX Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Coagulation Factor IX Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Coagulation Factor IX Sales Market Share in Value by Application in 2025 Figure 39. North America Coagulation Factor IX Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 40. North America Coagulation Factor IX Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Coagulation Factor IX Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Coagulation Factor IX Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Coagulation Factor IX Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. Europe Coagulation Factor IX Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Coagulation Factor IX Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Coagulation Factor IX Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Coagulation Factor IX Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Asia-Pacific Coagulation Factor IX Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Coagulation Factor IX Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Coagulation Factor IX Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Coagulation Factor IX Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Latin America Coagulation Factor IX Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Coagulation Factor IX Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Coagulation Factor IX Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Coagulation Factor IX Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Middle East and Africa Coagulation Factor IX Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Coagulation Factor IX Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Coagulation Factor IX Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Coagulation Factor IX Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Coagulation Factor IX Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Coagulation Factor IX (Plasma Derived)
  • Coagulation Factor IX (Recombinant)
Applications
  • Adult
  • Kids
Companies covered
  • Takeda
  • Novo Nordisk
  • Pfizer
  • Baxter
  • Sanquin
  • Grifols
  • CSL Behring
  • Bioverativ
  • Aptevo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Coagulation Factor IX Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Coagulation Factor IX Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Coagulation Factor IX Market by Type
  6. 1.3.1 Coagulation Factor IX (Plasma Derived)
  7. 1.3.2 Coagulation Factor IX (Recombinant)
  8. 1.4 Global Coagulation Factor IX Market Size by Type
  9. 1.4.1 Global Coagulation Factor IX Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Coagulation Factor IX Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Coagulation Factor IX Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Coagulation Factor IX Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Coagulation Factor IX Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Coagulation Factor IX Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Coagulation Factor IX Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Coagulation Factor IX Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Coagulation Factor IX Industry Trends
  2. 2.2 Coagulation Factor IX Industry Drivers
  3. 2.3 Coagulation Factor IX Industry Opportunities and Challenges
  4. 2.4 Coagulation Factor IX Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Coagulation Factor IX Revenue (2021-2026)
  2. 3.2 Global Top Players by Coagulation Factor IX Sales (2021-2026)
  3. 3.3 Global Top Players by Coagulation Factor IX Price (2021-2026)
  4. 3.4 Global Coagulation Factor IX Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Coagulation Factor IX Major Company Production Sites & Headquarters
  6. 3.6 Global Coagulation Factor IX Company, Product Type & Application
  7. 3.7 Global Coagulation Factor IX Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Coagulation Factor IX Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Coagulation Factor IX Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Coagulation Factor IX Tier 1, Tier 2, and Tier 3
4 Coagulation Factor IX Regional Status and Outlook
  1. 4.1 Global Coagulation Factor IX Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Coagulation Factor IX Historic Market Size by Region
  3. 4.2.1 Global Coagulation Factor IX Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Coagulation Factor IX Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Coagulation Factor IX Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Coagulation Factor IX Forecasted Market Size by Region
  7. 4.3.1 Global Coagulation Factor IX Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Coagulation Factor IX Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Coagulation Factor IX Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Coagulation Factor IX by Application
  1. 5.1 Coagulation Factor IX Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Kids
  4. 5.2 Global Coagulation Factor IX Market Size by Application
  5. 5.2.1 Global Coagulation Factor IX Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Coagulation Factor IX Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Coagulation Factor IX Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Coagulation Factor IX Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Coagulation Factor IX Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Coagulation Factor IX Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Coagulation Factor IX Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Coagulation Factor IX Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Coagulation Factor IX Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk Coagulation Factor IX Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Coagulation Factor IX Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Baxter
  20. 6.4.1 Baxter Company Information
  21. 6.4.2 Baxter Business Overview
  22. 6.4.3 Baxter Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Baxter Coagulation Factor IX Product Portfolio
  24. 6.4.5 Baxter Recent Developments
  25. 6.5 Sanquin
  26. 6.5.1 Sanquin Company Information
  27. 6.5.2 Sanquin Business Overview
  28. 6.5.3 Sanquin Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanquin Coagulation Factor IX Product Portfolio
  30. 6.5.5 Sanquin Recent Developments
  31. 6.6 Grifols
  32. 6.6.1 Grifols Company Information
  33. 6.6.2 Grifols Business Overview
  34. 6.6.3 Grifols Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Grifols Coagulation Factor IX Product Portfolio
  36. 6.6.5 Grifols Recent Developments
  37. 6.7 CSL Behring
  38. 6.7.1 CSL Behring Company Information
  39. 6.7.2 CSL Behring Business Overview
  40. 6.7.3 CSL Behring Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CSL Behring Coagulation Factor IX Product Portfolio
  42. 6.7.5 CSL Behring Recent Developments
  43. 6.8 Bioverativ
  44. 6.8.1 Bioverativ Company Information
  45. 6.8.2 Bioverativ Business Overview
  46. 6.8.3 Bioverativ Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bioverativ Coagulation Factor IX Product Portfolio
  48. 6.8.5 Bioverativ Recent Developments
  49. 6.9 Aptevo
  50. 6.9.1 Aptevo Company Information
  51. 6.9.2 Aptevo Business Overview
  52. 6.9.3 Aptevo Coagulation Factor IX Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Aptevo Coagulation Factor IX Product Portfolio
  54. 6.9.5 Aptevo Recent Developments
7 North America by Country
  1. 7.1 North America Coagulation Factor IX Sales by Country
  2. 7.1.1 North America Coagulation Factor IX Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Coagulation Factor IX Sales by Country (2021-2026)
  4. 7.1.3 North America Coagulation Factor IX Sales Forecast by Country (2027-2032)
  5. 7.2 North America Coagulation Factor IX Market Size by Country
  6. 7.2.1 North America Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Coagulation Factor IX Market Size by Country (2021-2026)
  8. 7.2.3 North America Coagulation Factor IX Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Coagulation Factor IX Sales by Country
  2. 8.1.1 Europe Coagulation Factor IX Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Coagulation Factor IX Sales by Country (2021-2026)
  4. 8.1.3 Europe Coagulation Factor IX Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Coagulation Factor IX Market Size by Country
  6. 8.2.1 Europe Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Coagulation Factor IX Market Size by Country (2021-2026)
  8. 8.2.3 Europe Coagulation Factor IX Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Coagulation Factor IX Sales by Country
  2. 9.1.1 Asia-Pacific Coagulation Factor IX Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Coagulation Factor IX Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Coagulation Factor IX Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Coagulation Factor IX Market Size by Country
  6. 9.2.1 Asia-Pacific Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Coagulation Factor IX Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Coagulation Factor IX Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Coagulation Factor IX Sales by Country
  2. 10.1.1 South America Coagulation Factor IX Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Coagulation Factor IX Sales by Country (2021-2026)
  4. 10.1.3 South America Coagulation Factor IX Sales Forecast by Country (2027-2032)
  5. 10.2 South America Coagulation Factor IX Market Size by Country
  6. 10.2.1 South America Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Coagulation Factor IX Market Size by Country (2021-2026)
  8. 10.2.3 South America Coagulation Factor IX Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Coagulation Factor IX Sales by Country
  2. 11.1.1 Middle East and Africa Coagulation Factor IX Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Coagulation Factor IX Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Coagulation Factor IX Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Coagulation Factor IX Market Size by Country
  6. 11.2.1 Middle East and Africa Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Coagulation Factor IX Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Coagulation Factor IX Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Coagulation Factor IX Value Chain Analysis
  2. 12.1.1 Coagulation Factor IX Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Coagulation Factor IX Production Mode & Process
  7. 12.2 Coagulation Factor IX Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Coagulation Factor IX Distributors
  10. 12.2.3 Coagulation Factor IX Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst